It is not natural disasters (like hurricanes or storms) which block access to TB care services most times, but manmade barriers that fuel injustices, inequities, ... Mar 11
The greater danger for most of us is not that our aim is too high and we miss it, but that it is too low ... Feb 27
Despite glaring gaps, there is historic progress made in India too in fight against TB. India saw the largest-ever rollout of WHO recommended molecular ... Feb 15
TB globally, out of which 410,000 cases were of drug-resistant TB. Moreover only less than half of those with drug-resistant TB (43%) ... Feb 05
Let us together defeat Cancer. Over 1 lakh participants from across 130 countries are expected to participate. The run will be held in Hybrid mode. ... Oct 27
Alleviate cancer burden through Education, Early Detection, Treatment, Rehabilitation and cutting-edge Research: Dr Chinababu Sunkavalli, Senior Consultant Robotic Surgical Oncologist and Founder of Grace ... Oct 25
Cyberabad Police will be with the organisers of the run in this endeavour. The run is to be held on 8th October, with 1 lakh ... Oct 12
Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
By virtue of the settlement, NATCO and Breckenridge have been granted a license permitting the launch of their generic carfilzomib products on a date that ... Jun 14
Top ten mid cap Indian pharma stocks , January 2021... Jan 07
... Dec 19
Rivaroxaban is currently sold by Bayer under the brand name of Xarelto, in the Indian market.... Dec 18
Celgene, sells Pomalidomide Capsules under the Brand name POMALYST, for the treatment of patients suffering from multiple myeloma cancer... Nov 13
Lupin launches generic version of Novartis's Tykerb Tablets... Sep 30
Lupin announced today the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance partner Natco Pharma Ltd received final approval for its ANDA from ... Sep 30
Researchers at Columbia University are conducting this critical study to assess CQ as prophylaxis against COVID-19 in healthcare workers.... May 23
Hyderabad based NATCO Pharma Limited has recorded consolidated total revenue of INR 513.0 Crore for the Third quarter ended on 31st December, 2019, as ... Feb 18
... Sep 13
-Advertisements-
Saturday, June 01, 2024
.jpg)
